Able Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$296K Sell
21,182
-13,691
-39% -$192K 0.08% 97
2025
Q4
$502K Sell
34,873
-7,763
-18% -$117K 0.16% 72
2025
Q3
$679K Buy
42,636
+15,872
+59% +$261K 0.26% 60
2025
Q2
$474K Buy
+26,764
New +$521K 0.24% 65

Other funds holding BTAL

Able Wealth Management's BTAL Position: Q1 2026 in Review

Able Wealth Management reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 39% in Q1 2026, selling an estimated $192K and leaving 21,182 shares worth $296K. The position accounts for 0.08% of the portfolio, ranked #97.

Able Wealth Management first reported a position in BTAL in Q2 2025 and has held it in 4 quarters since. The position peaked at $679K in Q3 2025. 87 funds tracked by Wall St. Rank hold BTAL as of Q1 2026.

  • Able Wealth Management held 21,182 shares of AGF US Market Neutral Anti-Beta Fund worth $296K as of Q1 2026.
  • Able Wealth Management sold 13,691 AGF US Market Neutral Anti-Beta Fund shares in Q1 2026, an estimated $192K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.08% of Able Wealth Management's portfolio in Q1 2026, its #97 holding.
  • Able Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2025 and has held it in 4 quarters since.
  • Able Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $679K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2026.

Based on Able Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.